Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Transl Psychiatry ; 13(1): 186, 2023 06 03.
Article in English | MEDLINE | ID: covidwho-20233704

ABSTRACT

To assess the inter-relationships between residual depressive symptoms (RDS) and Internet addiction (IA) using network analysis among clinically stable adolescents with major psychiatric disorders during the COVID-19 pandemic. RDS and IA were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Internet Addiction Test (IAT), respectively. Central symptoms and bridge symptoms in the network model were examined. A total of 1,454 adolescents met the study criteria and were included in the analyses. The prevalence of IA was 31.2% (95% CI: 28.8%-33.6%). In the network analysis, the nodes IAT15 ("Preoccupation with the Internet"), PHQ2 ("Sad mood"), and PHQ1 ("Anhedonia") were the most central symptoms in the IA-RDS network model. Bridge symptoms included IAT10 ("Sooth disturbing about your Internet use"), PHQ9 ("Suicide ideation"), and IAT3 ("Prefer the excitement online to the time with others"). Additionally, PHQ2 ("Sad mood") was the main node linking "Anhedonia" to other IA clusters. Internet addiction was common among clinically stable adolescents with major psychiatric disorders during the COVID-19 pandemic. Core and bridge symptoms identified in this study could be prioritized as targets for the prevention and treatment of IA in this population.


Subject(s)
Behavior, Addictive , COVID-19 , Mental Disorders , Humans , Adolescent , Depression/epidemiology , Internet Addiction Disorder/epidemiology , Pandemics , Behavior, Addictive/epidemiology , COVID-19/epidemiology , Mental Disorders/epidemiology , Mental Disorders/psychology , Anhedonia , Internet
2.
researchsquare; 2023.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-3001833.v1

ABSTRACT

Background There is overwhelming evidence indicating that depression may be reduced by physical activity (PA) but studies in lower- and middle-income countries and those that involved data at higher physical activity doses were underrepresented. The current study investigated the associations between PA levels (vigorous, moderate, walking and sitting) and depression, and tested whether age and gender moderates the link between PA and depression during the COVID-19 pandemic.Method Participants were 857 adults (51.0% women; aged 18–69, mean age = 29.71, SD = 10.84 years) who completed an online survey as part of the General Health, Speech and Physical Activity Relationship Assessment Study in Nigeria. Physical activity was assessed using the International Physical Activity Questionnaire (IPAQ) while depression was measured using the Patient Health Questionnaire (PHQ-9).Results Results of Hayes PROCESS macro indicated that those who engaged in vigorous PA reported lower levels of depression. Sitting, walking and moderate PA were not significantly associated with depressive symptoms. Older participants reported less symptoms of depression. Women had higher depressive symptoms compared to men. The interactions of age and gender with the PA levels were not significant, which showed that age and gender did not moderate the relationships of PA and depression.Conclusion Health practitioners should encourage people to engage in vigorous PA in order to reduce levels of depression and improve mental health in the general population.


Subject(s)
COVID-19 , Depressive Disorder , Anhedonia
3.
Int J Psychophysiol ; 186: 1-9, 2023 04.
Article in English | MEDLINE | ID: covidwho-2220809

ABSTRACT

Deficits in motivational functioning including impairments in reward learning or reward sensitivity are common in psychiatric disorders characterized by anhedonia. Recently, anhedonic symptoms have been exacerbated by the pandemic caused by the Coronavirus disease 2019 (COVID-19) in the general population. The present study examined the putative associations between loss of smell (anosmia) and taste (ageusia) sensitivity, irrespective of COVID-19 infection, and anhedonia, measured by a signal-detection task probing the ability to modify behavior as a function of rewards (Probabilistic Reward Task; PRT). Tonic heart rate variability (HRV) was included in the model, due to its association with both smell and taste sensitivity as well as motivational functioning. The sample included 114 healthy individuals (81 females; mean age 22.2 years), who underwent a laboratory session in which dispositional traits, resting HRV and PRT performance were assessed, followed by a 4-days ecological momentary assessment to obtain daily measures of anosmia and ageusia. Lower levels of tonic HRV and lower momentary levels of smell and taste sensitivity were associated with impaired reward responsiveness and ability to shape future behavioral choices based on prior reinforcement experiences. Overall, the current results provide initial correlational evidence that could be fruitfully used to inform future experimental investigations aimed at elucidating the disruptive worldwide mental health consequences triggered by the pandemic.


Subject(s)
Ageusia , COVID-19 , Olfaction Disorders , Female , Humans , Young Adult , Adult , COVID-19/complications , Smell , Ageusia/epidemiology , Ageusia/etiology , Heart Rate , SARS-CoV-2 , Anhedonia , Anosmia/complications
4.
BMC Pregnancy Childbirth ; 22(1): 937, 2022 Dec 15.
Article in English | MEDLINE | ID: covidwho-2196105

ABSTRACT

BACKGROUND: The positive predictive rate of the Japanese version of the Edinburgh Postnatal Depression Scale (EPDS) is lower than those of other versions. This study aimed to confirm whether the EPDS Japanese version reflects actual symptom frequency and to examine the possibility of improving the positive predictive rate. METHODS: This is a methodological study aimed at improving the positive predictive value of EPDS. The participants were 63 non-pregnant and 382 pregnant women. They answered the 10 questions of the Japanese version of the EPDS and reported the specific number of days as the frequency. The EPDS score (EPDS-S) and the frequency score (FREQ-S) were calculated for three factors of emotion: anhedonia, anxiety, and depression. RESULTS: The positive rates of the EPDS-S and FREQ-S in pregnant women were 6% and 8%, respectively, which were lower than those in non-pregnant women (17%). On comparing the EPDS-S with the FREQ-S, a significant underestimation of frequency was observed in approximately 3% of pregnant women. The FREQ-S showed better internal consistency than the EPDS-S. Among the factors of emotion, women tended to rate anhedonia lower in the EPDS-S than in the frequency scale. CONCLUSION: Pregnant women tended to report a lower frequency on the Japanese version of the EPDS than their actual symptom frequency, which was especially true for those with a desire to self-harm. The combined use of the FREQ-S and EPDS-S can prevent underestimation and help improve the detection rate of depression.


Subject(s)
Depression, Postpartum , Female , Humans , Pregnancy , Anhedonia , Depression/diagnosis , Depression, Postpartum/diagnosis , Pregnant Women , Psychiatric Status Rating Scales , Japan , Language
5.
J Affect Disord ; 324: 190-198, 2023 03 01.
Article in English | MEDLINE | ID: covidwho-2165451

ABSTRACT

INTRODUCTION: Recently, in the view of network analysis, depression has been conceptualized as a complex and dynamic network model combining individual symptoms. To date, no studies have systematically examined and compared depressive symptom networks across different populations. METHODS: A total of 36,105 participants were recruited and asked to complete the Patient Health Questionnaire-9 among junior high school students, senior high school students, college students, and elderly adults who were more susceptible to depression during the COVID-19 lockdown in China. In the analysis, we applied the optimal cutoff score ≥ 8 for students and a score ≥ 6 for elderly adults to identify 5830 participants who were likely to be depressed. The index of "strength" was used to identify central symptoms in the network structure. RESULTS: The results showed that Sad Mood was the most central symptom among junior high school students, senior high school students, and college students, but the most central symptom in the elderly was Guilt. Among the top three central symptoms, Suicide Ideation was unique to senior high school students, while Anhedonia was most prevalent among college students. Guilt - Suicide Ideation, Anhedonia - Energy, Anhedonia - Sad Mood, and Sleep - Energy showed the strongest association among junior and senior high school students, college students, and elderly adults, respectively. NCT (i.e., Network Comparison Test) suggested that the network's global connectivity was ultimately inconsistent, but the network structure remained roughly intact. CONCLUSION: In treatment, targeting central symptoms may be critical to alleviating depression.


Subject(s)
COVID-19 , Communicable Disease Control , Depressive Disorder, Major , Aged , Humans , Anhedonia , COVID-19/prevention & control , Depressive Disorder, Major/epidemiology , Depressive Disorder, Major/psychology , Pandemics , Students/psychology , Students/statistics & numerical data , Health Surveys , Adolescent , Young Adult
6.
J Affect Disord ; 324: 480-488, 2023 03 01.
Article in English | MEDLINE | ID: covidwho-2165447

ABSTRACT

BACKGROUND: Persons with suicidality including suicidal ideation (SI), suicide plans (SP) and/or suicide attempts (SA) are at higher risk for future suicide than those without suicidality. To reduce the risk of future suicide, it is important to understand symptoms of emotional distress that have the strongest links with SI, SP and SA. This network analysis examined item-level relations of depressive and anxiety symptoms with suicidality among adolescents during the COVID-19 pandemic. METHODS: Adolescents between 12 and 20 years of age were assessed with the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and individual binary reponse (no/yes) items assessing SI, SP, and SA during the pandemic. The structure of depressive symptoms, anxiety symptoms and suicidality was characterized using "Expected Influence" and "Bridge Expected Influence" as centrality indices in the symptom network. Network stability was tested using a case-dropping bootstrap procedure. Node-specific predictive betweenness was computed to examine short paths of anhedonia, other depressive symptoms and anxiety symptoms with suicidality. A Network Comparison Test (NCT) was conducted to examine whether network characteristics differed based on gender. RESULTS: Prevalence rates of depressive symptoms, anxiety symptoms, and suicidality were 44.60 % (95% confidence interval (CI) = 41.53-47.67 %), 31.12 % (95%CI = 28.26-33.98 %), and 16.95 % (95%CI = 14.63-19.26 %), respectively, in the study sample. The network analysis identified GAD3 ("Worry too much") as the most central symptom, followed by GAD6 ("Irritability") and PHQ6 ("Guilt") in the sample. Additionally, PHQ6 ("Guilt"), GAD6 ("Irritability"), and PHQ2 ("Sad mood") were bridge nodes linking depressive and anxiety symptoms with suicidality. A flow network indicated that the connection between S ("Suicidality") and PHQ6 ("Guilt") reflected the strongest connection, followed by connections of S ("Suicidality") with GAD2 ("Uncontrollable worrying"), and S ("Suicidality") with PHQ2 ("Sad mood"). Finally, PHQ2 ("Sad mood") was the main bridge node linking anhedonia with other depressive and anxiety symptoms and suicidality in the sample. CONCLUSIONS: Findings highlight the potential importance of reducing specific depressive and anxiety symptoms as possible means of reducing suicidality among adolescents during the pandemic. Central symptoms and key bridge symptoms identified in this study should be targeted in suicide prevention for at-risk adolescents.


Subject(s)
COVID-19 , Suicidal Ideation , Humans , Adolescent , Depression/epidemiology , Depression/psychology , Anhedonia , Pandemics , COVID-19/epidemiology , Anxiety/epidemiology , Anxiety/psychology , Irritable Mood
7.
J Affect Disord ; 324: 317-324, 2023 03 01.
Article in English | MEDLINE | ID: covidwho-2159163

ABSTRACT

BACKGROUND: Anhedonia is a suicide risk factor among adolescent patients with recurrent depressive disorder (depression hereafter). This study examined associations between suicidal ideation (SI) and residual depressive symptoms (RSD), including anhedonia, among clinically stable adolescents with depression. METHOD: A network analysis was performed to examine the association between RDS and SI among adolescents with depression. Node-specific predictive betweenness was computed to examine short paths between anhedonia and SI. Additionally, a Network Comparison Test (NCT) was conducted to examine gender differences in derived network model characteristics. RESULTS: The network analysis identified close associations of PHQ9 ("Suicide ideation") with PHQ1 ("Anhedonia") as well as some other RDS including PHQ6 ("Guilt"), PHQ2 ("Sad mood") and PHQ8 ("Motor disturbances"). Additionally, PHQ2 ("Sad mood") and PHQ4 ("Fatigue") were the main bridge nodes linking anhedonia and SI. Comparisons of network models did not find significant differences in network global strength or edge weights. LIMITATION: Causal relations between anhedonia and SI could not be determined due to the cross-sectional study design. CONCLUSIONS: SI was directly related to Anhedonia in addition to Guilt, Sad mood and Motor disturbances. Sad mood and Fatigue were the main bridge nodes linking Anhedonia and SI. To reduce the risk of SI among clinically stable adolescents with depression during the COVID-19 pandemic, specific RDS including Anhedonia, Guilt, Sad mood, Motor disturbances and Fatigue should be targeted in interventions.


Subject(s)
COVID-19 , Depressive Disorder , Humans , Adolescent , Depression/epidemiology , Suicidal Ideation , Cross-Sectional Studies , Pandemics , Anhedonia
8.
Int J Environ Res Public Health ; 19(22)2022 Nov 18.
Article in English | MEDLINE | ID: covidwho-2115999

ABSTRACT

Alexithymia and anhedonia are associated with psychiatric disorders, such as depression and anxiety. The COVID-19 pandemic lead to a significant deterioration in the mental health of the population. It is therefore important to examine the effects of lockdown on alexithymia and anhedonia and their relationships with anxiety and depression. We compared the scores and characteristics of 286 patients divided into two groups: one before lockdown (group 1, N = 127), the other during the progressive lockdown release (group 2, N = 159). The groups were homogeneous in terms of age, sex ratio, socio-professional categories, and somatic and psychiatric comorbidities. The groups were compared on the Toronto Alexithymia Scale (TAS-20) measuring alexithymia, the Beck Depression Inventory (BDI-II) measuring depression, the anhedonia subscale of the BDI-II measuring state-anhedonia and the State Trait Anxiety Inventory (STAI) measuring state and trait anxiety. The ratio of alexithymic subjects in group 1 is 22.83% to 33.33% in group 2 (p-value = 0.034). This suggests a significant increase in the number of alexithymic patients after lockdown. We did not observe any difference in the proportion of depressed and anxious subjects before or after lockdown. Among the different scales, higher scores were only found on the cognitive factor of alexithymia on group 2 comparatively to group 1. This study indicates an increase in the proportion of alexithymic subjects following lockdown. Unexpectedly, this was unrelated to depression, anxiety or anhedonia levels, which remained stable. Further studies are needed to confirm this result and to evaluate precisely which factors related to the lockdown context are responsible for such an increase.


Subject(s)
Affective Symptoms , COVID-19 , Humans , Affective Symptoms/psychology , Anhedonia , Prevalence , Depression/epidemiology , Depression/complications , COVID-19/epidemiology , Belgium , Pandemics , Communicable Disease Control , Anxiety/psychology
9.
Neurol Sci ; 43(8): 4605-4609, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1826536

ABSTRACT

INTRODUCTION: The COVID-19 pandemic led to psychological consequences on people's mental health, representing a condition of increased vulnerability for the weakest sections of population, including elderly patients with Parkinson's disease (PD). This longitudinal study aimed at exploring the impact of the most frequent non-motor symptoms and their contribute on health-related quality of life of PD patients after the COVID-19 outbreak, in comparison with the pre-pandemic status. METHODS: Forty-two non-demented PD patients underwent a first assessment between December 2018 and January 2020 (T0). Then, between March and May 2021 (T1), they were contacted again and asked to complete the second assessment. Levels of global functioning, several non-motor symptoms (i.e. depression, apathy, anxiety, anhedonia) and health-related quality of life were investigated. RESULTS: Results of the the paired Wilcoxon signed-rank test showed that at T1, PD patients scored lower on the emotional subscale of the DAS, Z = - 2.49; p = 0.013; Cohen dz = 0.691. Higher scores of the TEPS total score, Z = - 2.38; p = 0.025; Cohen dz = 0.621, and LEDD, Z = - 2.63; p = 0.008; Cohen dz = 0.731, were also reported at T1. CONCLUSION: The present study suggested that self-isolation at home might lead to a reduction of apathy and anhedonia in PD patients due to the increase in social support provided by families during COVID-19 restrictions. This evidence brings out the need of a consistent and persistent social support which might be represented by caregivers or/and social assistive robotics.


Subject(s)
COVID-19 , Parkinson Disease , Aged , Anhedonia , Humans , Longitudinal Studies , Pandemics , Parkinson Disease/complications , Parkinson Disease/diagnosis , Parkinson Disease/epidemiology , Quality of Life/psychology
10.
BMC Psychiatry ; 22(1): 280, 2022 04 20.
Article in English | MEDLINE | ID: covidwho-1808352

ABSTRACT

BACKGROUND: The Posttraumatic Stress Disorder Checklist (PCL-5) is the most widely used screening tool in assessing posttraumatic stress disorder symptoms, based on the Diagnostic and Statistical Manual of Mental disorders (DSM-5) criteria. This study aimed to evaluate the psychometric properties of the newly translated Bangla PCL-5. METHODS: A cross-sectional survey was carried out among 10,605 individuals (61.0% male; mean age: 23.6 ± 5.5 [13-71 years]) during May and June 2020, several months after the onset of the COVID-19 outbreak in Bangladesh. The survey included the Bangla PCL-5 and the PHQ-9 depression scale. We used confirmatory factor analysis to test the four-factor DSM-5 model, the six-factor Anhedonia model, and the seven-factor hybrid model. RESULTS: The Bangla PCL-5 displayed adequate internal consistency (Cronbach's alpha = 0.90). The Bangla PCL-5 score was significantly correlated with scores of the PHQ-9 depression scale, confirming strong convergent validity. Confirmatory factor analyses indicated the models had a good fit to the data, including the four-factor DSM-5 model, the six-factor Anhedonia model, and the seven-factor hybrid model. Overall, the seven-factor hybrid model exhibited the best fit to the data. CONCLUSIONS: The Bangla PCL-5 appears to be a valid and reliable psychometric screening tool that may be employed in the prospective evaluation of posttraumatic stress disorder in Bangladesh.


Subject(s)
COVID-19 , Stress Disorders, Post-Traumatic , Adolescent , Adult , Anhedonia , Checklist , Cross-Sectional Studies , Diagnostic and Statistical Manual of Mental Disorders , Female , Humans , Male , Psychometrics , Reproducibility of Results , Stress Disorders, Post-Traumatic/diagnosis , Young Adult
11.
Int J Mol Sci ; 23(4)2022 Feb 13.
Article in English | MEDLINE | ID: covidwho-1715398

ABSTRACT

The phenomenon of individual variability in susceptibility/resilience to stress and depression, in which the hippocampus plays a pivotal role, is attracting increasing attention. We investigated the potential role of hippocampal cyclooxygenase-2 (COX-2), which regulates plasticity, neuroimmune function, and stress responses that are all linked to this risk dichotomy. We used a four-week-long chronic mild stress (CMS) paradigm, in which mice could be stratified according to their susceptibility/resilience to anhedonia, a key feature of depression, to investigate hippocampal expression of COX-2, a marker of microglial activation Iba-1, and the proliferation marker Ki67. Rat exposure, social defeat, restraints, and tail suspension were used as stressors. We compared the effects of treatment with either the selective COX-2 inhibitor celecoxib (30 mg/kg/day) or citalopram (15 mg/kg/day). For the celecoxib and vehicle-treated mice, the Porsolt test was used. Anhedonic (susceptible) but not non-anhedonic (resilient) animals exhibited elevated COX-2 mRNA levels, increased numbers of COX-2 and Iba-1-positive cells in the dentate gyrus and the CA1 area, and decreased numbers of Ki67-positive cells in the subgranular zone of the hippocampus. Drug treatment decreased the percentage of anhedonic mice, normalized swimming activity, reduced behavioral despair, and improved conditioned fear memory. Hippocampal over-expression of COX-2 is associated with susceptibility to stress-induced anhedonia, and its pharmacological inhibition with celecoxib has antidepressant effects that are similar in size to those of citalopram.


Subject(s)
Anhedonia/physiology , Cyclooxygenase 2/metabolism , Hippocampus/metabolism , Stress, Psychological/metabolism , Anhedonia/drug effects , Animals , Antidepressive Agents/pharmacology , Celecoxib/pharmacology , Citalopram/pharmacology , Depression/drug therapy , Depression/metabolism , Hindlimb Suspension/physiology , Hippocampus/drug effects , Male , Mice , Mice, Inbred C57BL , Rats , Rats, Wistar , Selective Serotonin Reuptake Inhibitors/pharmacology , Stress, Psychological/drug therapy , Swimming/physiology
12.
BMC Pregnancy Childbirth ; 21(1): 845, 2021 Dec 28.
Article in English | MEDLINE | ID: covidwho-1638197

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has recently become the most important issue in the world. Very few reports in Japan have examined the impact of the COVID-19 pandemic on peripartum mental health. We examined the status of postpartum mental health before and during COVID-19 pandemic from a consecutive database in a metropolitan area of Japan. METHODS: The subjects were women who had completed a maternity health check-up at a core regional hospital in Yokohama during the period from April 1, 2017, to December 31, 2020. We collected the subjects' scores for the Edinburgh Postnatal Depression Scale (EPDS) and the Mother-to-Infant Bonding Scale (MIBS) at 1 month postpartum. The subjects were divided into four groups (three Before COVID-19 groups and a During COVID-19 group). MANOVA and post-hoc tests were used to determine mental health changes in the postpartum period among the four groups. RESULTS: The Before and During COVID-19 groups contained 2844 and 1095 mothers, respectively. There were no significant difference in the total scores of the EPDS and MIBS among the four groups. However, the EPDS items related to anxiety factors were significantly higher and the EPDS items related to anhedonia and depression factors (excluding thoughts of self-harm) were significantly lower in the During COVID-19 group. CONCLUSION: The EPDS scores changed in connection with the COVID-19 pandemic. Anxiety, which represent hypervigilance, was significantly higher and anhedonia and depression were significantly lower in the During COVID-19 group. Our results may reflect COVID-19-related health concerns and a lack of social support caused by the COVID-19 pandemic.


Subject(s)
COVID-19/psychology , Mental Health , Mothers/psychology , Postpartum Period/psychology , Adult , Anhedonia , Anxiety/epidemiology , Depression, Postpartum/epidemiology , Female , Humans , Japan/epidemiology , Psychiatric Status Rating Scales , Retrospective Studies
13.
psyarxiv; 2021.
Preprint in English | PREPRINT-PSYARXIV | ID: ppzbmed-10.31234.osf.io.he53c

ABSTRACT

Temporal patterns of affective functioning such as emotional inertia and instability may predict increases in depressive symptoms. However, the investigation of maladaptive emotion regulation’s role in affect dynamics and depressive symptoms at the within-individual level is still lacking. We collected intensive longitudinal data regarding momentary maladaptive emotion regulation strategies (rumination and expressive suppression) and negative affective states (NA) (measured multiple times a day), perceived stressors and depressive symptoms (measured every three days) from a general population sample during the COVID-19 pandemic’s first wave in Hungary. The final dataset included 7117 affective states surveys from 125 participants, which were aggregated in 460 three-day measurement windows. Multilevel SEM models were fit to test whether affect dynamics mediate the association between maladaptive emotion regulation strategies, negative affect intensity, and two domains of depression, anhedonia, and negative mood and thoughts. Within and between individuals, rumination indirectly predicted NA intensity and negative mood and thoughts through elevated NA instability and NA inertia. Expressive suppression had a negative indirect effect on NA intensity via NA inertia at the within-person level, while this mediation effect was positive at the between-person level. Moreover, affect dynamics were positively connected to depressive symptoms and these associations were mediated by NA intensity. These suggest that disturbances in emotion regulation are indirectly connected to depressive symptoms, mediated by specific temporal patterns in affective functioning. These findings hold both at the within- and the between-individual level. Our findings may facilitate automated depression risk assessment based on simple affective and emotion regulation time series.


Subject(s)
COVID-19 , Anhedonia
14.
psyarxiv; 2021.
Preprint in English | PREPRINT-PSYARXIV | ID: ppzbmed-10.31234.osf.io.y9svn

ABSTRACT

A particularly vulnerable yet often-ignored subpopulation is Chinese international students (CIS). Literature suggests CIS suffer from high prevalence of common mental health disorders. Recent advances popularize the use of network analysis on psychopathology data. Our study (N = 421) is the first to investigate depression and anxiety simultaneously from a network perspective in CIS. Results of the Gaussian graphical model (GGM) suggested that: (1) central symptoms identified via the centrality index of strength included depressive symptoms of “anhedonia” and anxiety symptoms of “restlessness” and “tense”; (2) bridge symptoms identified via the bridge expected influence index included depressive symptom of “psychomotor agitation/retardation” and anxiety symptoms of “afraid” and “restlessness”. Results of the Bayesian directed acyclic graph (DAG) demonstrated the predictive priority of depressive symptoms of “anhedonia” and “sadness” in driving comorbidity. The network analyses highlight the node of “anhedonia” (a central node in GGM and the top node in DAG) and several other mostly physical symptoms including “restlessness”, “tense”, “psychomotor agitation/retardation”, and “afraid” as candidates for interventions and show great value in generating clinical insights beyond western sample. Implications and limitations are discussed.


Subject(s)
COVID-19 , Anxiety Disorders , Psychomotor Agitation , Anhedonia
15.
researchsquare; 2021.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-894681.v1

ABSTRACT

Older age renders individuals vulnerable during public emergency crises. Considering that older adults are a highly heterogeneous and continuously growing demographic subgroup, this study aimed to assess the mental health impact of COVID-19 on two groups of older patients: a group of chronic physical disease and a group of chronic mental disease. A total of 102 patients completed the Fear of COVID-19 Scale, the Generalized Anxiety Disorder scale, the Brief Patient Health Questionnaire (PHQ-9) and several questions regarding demographic characteristics. Suicidality was assessed by the 9 th item of the PHQ-9.According to the results, older chronic disease patients showed higher levels of fear, whereas anxiety and depressive symptoms were present mainly in the group of older psychiatric patients. Suicidality was reported from a subtotal of 25.4% that was composed of 7.8% chronic disease patients and 17.6% psychiatric patients. Chronic physical disease and higher anxiety predicted more severe COVID-19-related fear.


Subject(s)
Anxiety Disorders , Anhedonia , Mental Disorders , Intellectual Disability , Chronic Disease , COVID-19
16.
psyarxiv; 2021.
Preprint in English | PREPRINT-PSYARXIV | ID: ppzbmed-10.31234.osf.io.af5dh

ABSTRACT

Background: In order to understand the intricate patterns of interplay connected to the formation and maintenance of depressive symptomatology, repeated measures investigations focusing on within-person relationships between psychopathological mechanisms and depressive components are required. Methods: This large-scale preregistered intensive longitudinal study conducted 68 240 observations of 1706 individuals in the general adult population across a 40-day period during the COVID-19 pandemic to identify the detrimental processes involved in depressive states. Daily responses were modeled using multi-level dynamic network analysis to investigate temporal associations across days, in addition to contemporaneous relationships between depressive components within a daily window. Results: Among the investigated psychopathological mechanisms, helplessness predicted the strongest across-day influence on depressive symptoms, while emotion regulation difficulties displayed more proximal interactions with symptomatology. Helplessness was further involved in the amplification of other theorized psychopathological mechanisms including rumination, the latter of which to a greater extent was susceptible toward being influenced rather than temporally influencing other components of depressive states. Distinctive symptoms of depression behaved differently, with depressed mood and anhedonia most prone to being impacted, while lethargy and worthlessness were more strongly associated with outgoing activity in the network. Conclusions: The main mechanism predicting amplifications of detrimental symptomatology was helplessness. Lethargy and worthlessness revealed greater within-person carry-over effects across days, providing preliminary indications that these symptoms may be more strongly associated with pushing individuals toward prolonged depressive state experiences. The psychopathological processes of rumination, helplessness, and emotion regulation only exhibited interactions with the depressed mood and worthlessness component of depression, being unrelated to lethargy and anhedonia. The findings have implications for the impediment of depressive symptomatology during and beyond the pandemic period. They further outline gaps in the literature concerning the identification of psychopathological processes intertwined with lethargy and anhedonia on the within-person level.


Subject(s)
COVID-19 , Anhedonia
17.
researchsquare; 2021.
Preprint in English | PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-659189.v1

ABSTRACT

Background: The coronavirus disease 2019 (COVID-19) pandemic has recently become the most important issue in the world. Very few reports in Japan have examined the impact of the COVID-19 pandemic on peripartum mental health. We examined the current status of postpartum mental health in a metropolitan area. Methods: : The subjects were women who had completed a maternity health check-up at a core regional hospital in Yokohama during the period from April 1, 2017, to December 31, 2020. We collected the subjects’ scores for the Edinburgh Postnatal Depression Scale (EPDS) and the Mother-to-Infant Bonding Scale (MIBS) at one month postpartum. The subjects were divided into four groups (three Before COVID-19 groups and a During COVID-19 group). MANOVA and post-hoc tests were used to determine mental health changes in the postpartum period among the four groups. Results: : The Before and During COVID-19 groups contained 2844 and 1095 mothers, respectively. There were no significant difference in the total scores of the EPDS and MIBS among the four groups. However, the EPDS items related to anxiety factors were significantly higher and the EPDS items related to anhedonia and depression factors (excluding thoughts of self-harm) were significantly lower in the During COVID-19 group. Conclusion: The EPDS scores changed in connection with the COVID-19 pandemic. Anxiety, which represent hypervigilance, was significantly higher and anhedonia and depression were significantly lower in the During COVID-19 group. Our results may reflect COVID-19-related health concerns and a lack of social support caused by the COVID-19 pandemic.


Subject(s)
COVID-19 , Anxiety Disorders , Intellectual Disability , Anhedonia
18.
Int J Neuropsychopharmacol ; 24(11): 859-866, 2021 11 12.
Article in English | MEDLINE | ID: covidwho-1254714

ABSTRACT

BACKGROUND: COVID-19 lockdown measures have caused severe disruptions to work and education and prevented people from engaging in many rewarding activities. Cannabis users may be especially vulnerable, having been previously shown to have higher levels of apathy and anhedonia than non-users. METHODS: In this survey study, we measured apathy and anhedonia, before and after lockdown measures were implemented, in n = 256 adult and n = 200 adolescent cannabis users and n = 170 adult and n = 172 adolescent controls. Scores on the Apathy Evaluation Scale (AES) and Snaith-Hamilton Pleasure Scale (SHAPS) were investigated with mixed-measures ANCOVA, with factors user group, age group, and time, controlling for depression, anxiety, and other drug use. RESULTS: Adolescent cannabis users had significantly higher SHAPS scores before lockdown, indicative of greater anhedonia, compared with adolescent controls (P = .03, η p2 = .013). Contrastingly, adult users had significantly lower scores on both the SHAPS (P < .001, η p2 = .030) and AES (P < .001, η p2 = .048) after lockdown compared with adult controls. Scores on both scales increased during lockdown across groups, and this increase was significantly smaller for cannabis users (AES: P = .001, η p2 = .014; SHAPS: P = .01, η p2 = .008). Exploratory analyses revealed that dependent cannabis users had significantly higher scores overall (AES: P < .001, η p2 = .037; SHAPS: P < .001, η p2 = .029) and a larger increase in scores (AES: P = .04, η p2 =.010; SHAPS: P = .04, η p2 = .010), compared with non-dependent users. CONCLUSIONS: Our results suggest that adolescents and adults have differential associations between cannabis use as well as apathy and anhedonia. Within users, dependence may be associated with higher levels of apathy and anhedonia regardless of age and a greater increase in levels during the COVID-19 lockdown.


Subject(s)
Anhedonia , Apathy , COVID-19 , Marijuana Abuse/psychology , Marijuana Smoking/psychology , Adolescent , Adult , Age Factors , Case-Control Studies , Female , Humans , Male , Surveys and Questionnaires , Young Adult
19.
psyarxiv; 2021.
Preprint in English | PREPRINT-PSYARXIV | ID: ppzbmed-10.31234.osf.io.r3cpt

ABSTRACT

Psychometric studies are needed to decide the most suitable instrument in psychological research. Whereas Beck Depression Inventory has more psychometrics studies in Spanish-speaking countries, Beck Anxiety Inventory has less evidence. Additionally, anhedonia is a crucial construct to understand the relationship between depression and anxiety and their outcomes. However, there a scarce psychometric studies in anhedonia measures in non-English languages. Therefore, the first objective was to describe the Beck Anxiety Inventory and Snaith-Hamilton Pleasure Scale (SHAPS) psychometric properties. The second objective was to evaluate the measurement invariance of two psychometric scales, the Beck Anxiety Inventory (BAI) and the Snaith-Hamilton Pleasure Scale (SHAPS), in 12 Spanish-speaking countries. The first included 1287 participants over 18 years of age from Chile. The second with a sample of 9954 participants from 12 Spanish-speaking countries. We analyze the construct, convergent, concurrent, and discriminant validities using confirmatory factor analysis and structural equation modeling. This study showed good internal consistency for both scales. First, we provided evidence for construct validity, convergent validity, concurrent validity, and discriminant validity in a Chilean sample. Secondly, we established measurement invariance between Chile and those other 11 countries. This study represents the most thorough psychometric analysis of the BAI and SHAPS in the context of which we are aware.


Subject(s)
Anxiety Disorders , COVID-19 , Anhedonia
20.
Eur Arch Psychiatry Clin Neurosci ; 272(1): 17-27, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1195164

ABSTRACT

Negative symptoms are core features of schizophrenia-spectrum disorders that are frequently observed across all phases of illness. By their nature, COVID-19 social isolation, physical distancing, and health precautions induce behavioural aspects of negative symptoms. However, it is unclear whether these prevention measures also lead to increases in experiential negative symptoms, whether such effects are equivalent across individual negative symptom domains, and if exacerbations occur equivalently across phases of illness. The current study compared negative symptom severity scores obtained during the pandemic to pre-pandemic assessments in two samples: (1) outpatients with chronic schizophrenia (SZ: n = 32) and matched healthy controls (CN: n = 31) and (2) individuals at clinical high risk for psychosis (CHR: n = 25) and matched CN (n = 30). Pre-pandemic ratings of negative symptoms were clinically elevated in SZ and CHR groups, which did not differ from each other in severity. In SZ, ratings obtained during the pandemic were significantly higher than pre-pandemic ratings for all 5 domains (alogia, blunted affect, anhedonia, avolition, and asociality) and item-level analyses indicated that exacerbations occurred on both experiential and behavioral symptoms of anhedonia, avolition, and asociality. In contrast, CHR only exhibited increases in anhedonia and avolition items during the pandemic compared to pre-ratings. Findings suggest that negative symptoms should be a critical treatment target during and after the pandemic in the schizophrenia spectrum given that they are worsening and critically related to risk for conversion, functional outcome, and recovery.


Subject(s)
COVID-19 , Outpatients , Pandemics , Psychotic Disorders , Schizophrenic Psychology , Anhedonia , COVID-19/epidemiology , COVID-19/psychology , Case-Control Studies , Chronic Disease , Humans , Outpatients/psychology , Psychotic Disorders/epidemiology , Risk Assessment , Schizophrenia/therapy
SELECTION OF CITATIONS
SEARCH DETAIL